
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 8 chart positions in 8 markets.
By chart position
- 🇦🇺AU · Medicine#8330K to 100K
- 🇸🇪SE · Medicine#9910K to 30K
- 🇦🇷AR · Medicine#2210K to 30K
- 🇮🇪IE · Medicine#983K to 10K
- 🇹🇭TH · Medicine#151500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
17K to 55K🎙 Daily cadence·229 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
55K to 182K🇦🇺55%🇸🇪16%🇦🇷16%+5 more - Active Followers
Loyal subscribers who consistently listen
22K to 73K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Is Copper the new Gold??! Co-PSMA trial in European Urology
Apr 23, 2026
27m 25s
EAU Prostate Cancer Guideline Update
Apr 12, 2026
28m 37s
Journal club #7 | proPSMA and Penile Fractures(!)
Apr 6, 2026
28m 09s
ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari
Apr 2, 2026
25m 11s
From Studio to Stage: GU Cast Live at EAU in London!
Mar 20, 2026
41m 13s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/23/26 | ![]() Is Copper the new Gold??! Co-PSMA trial in European Urology✨ | PSMA tracerbiochemical recurrence+3 | Professor Louise EmmettDr Matt Roberts | 64Cu-SAR-bisPSMA68Ga-PSMA-11+2 | — | PSMA tracerbiochemical recurrence+3 | — | 27m 25s | |
| 4/12/26 | ![]() EAU Prostate Cancer Guideline Update✨ | prostate cancerguideline updates+3 | Derya TilkiGianluca Giannarini | EAU Guideline CommitteeEAU Guideline Office | Melbourne | EAU Prostate Cancer GuidelineDerya Tilki+3 | — | 28m 37s | |
| 4/6/26 | ![]() Journal club #7 | proPSMA and Penile Fractures(!)✨ | prostate cancerPSMA PET/CT+3 | — | LancetBJUI | London | proPSMAPSMA PET/CT+6 | — | 28m 09s | |
| 4/2/26 | ![]() ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari✨ | clinical trialsoncology+4 | Rana McKayDeepak Kilari | Alliance for Clinical Trials in OncologyADT+3 | — | ASPIRE trialADT+5 | — | 25m 11s | |
| 3/20/26 | ![]() From Studio to Stage: GU Cast Live at EAU in London!✨ | live showurology+3 | — | EAU Scientific OfficeMediAVentures | London | urologylive podcast+3 | — | 41m 13s | |
| 3/13/26 | ![]() PRIMARY 2 is positive! PSMA PET/CT moves to early detection✨ | prostate cancerearly detection+3 | Dr James Buteau | Peter MacCallum Cancer CentreLancet Oncology | London | PRIMARY 2PSMA PET/CT+5 | — | 33m 44s | |
| 3/8/26 | ![]() Histolog digital microscopy | All you need to know!✨ | intra-operative margin assessmentprostate cancer surgery+3 | — | ORSI AcademySamantree Medical | — | intra-operative margin assessmentprostate cancer+4 | — | 38m 01s | |
| 3/6/26 | ![]() Win a trip to the APCCC in Lugano!!!✨ | prostate cancergiveaway+3 | — | APCCCEAU+2 | Lugano | APCCCLugano+3 | — | 1m 40s | |
| 2/28/26 | ![]() Journal Club #6 | POUT and SEMS✨ | urothelial cancertesticular cancer+3 | Dr Carlos DelgadoDr Elena Berg | POUT trialSEMS trial+4 | — | POUT trialSEMS trial+4 | — | 26m 24s | |
| 2/26/26 | ![]() ARPIs, SPARC and Organised Prostate Testing | With Anders Bjartell✨ | prostate cancerADT/ARPI doublets+4 | Anders Bjartell | Lund UniversityUniversity Hospital Malmo+1 | — | prostate cancerADT+5 | — | 40m 58s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/24/26 | ![]() Periop EV-Pembro | Do we even need cystectomy anymore?? EV-303 with Christof Vulsteke | Giant bladder cancer paper in NEJM this week with the highly anticipated results of the perioperative EV-Pembro trial (EV-303 / KN-905). Already we can say this is a landmark publicaion in bladder cancer that will change practice and even challenge the role of cystectomy (maybe)! Declan Murphy and Renu Eapen caught up with first author Christof Vulsteke (Integrated Cancer Centre, Ghent, BEL) when we were at ESMO Asia recently and had a chat about this work and how it will change practic... | 20m 46s | ||||||
| 2/22/26 | ![]() Neha and Amar on what really matters | Following on from last week's episode on "toxicity", we are delighted today to welcome back two great friends of GU Cast from the world of radiation oncology - ASTRO President Dr Neha Vapiwala (University of Pennsylvania), and European Urology Associate Editor, Dr Amar Kishan (University of California, Los Angeles). We go through Amar and Neha's letter to the editor following the recent paper in Eur Urol Oncol from the IRRADIATE registry, and dive into the opportunities we have working ... | 30m 43s | ||||||
| 2/8/26 | ![]() GU Toxicity, AI Toxicity & Twitter toxicity!!! | In case you missed it, or you've already abandoned Twitter (memo to self - must do that ourselves!), we witnessed some pretty toxic stuff over there in the past couple of weeks. Vile personal attacks, calls for resignations, accusations of nefarious behaviour etc etc, mostly triggered by an AI-generated infographic attempting to illustarte a recent paper in European Urology Oncology. We chat with first author Dr Riccardo Bertolo (University of Verona, ITA), about his first-hand experien... | 38m 22s | ||||||
| 1/9/26 | ![]() Journal Club #5 | Lamm BCG maintenance and CHAARTED | Happy New Year and welcome to Episode 5 of our monthly GU Cast Journal Club! Today we focus on two classic papers in non-invasive bladder cancer and metastatic prostate cancer. The Lamm RCT of maintenance BCG is a landmark trial for all sorts of reasons, published in J Urol in 2000. And the CHAARTED paper of chemohormonal therapy is the landmark trial of combination therapy in mHSPC, published in NEJM in 2015. We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delga... | 30m 52s | ||||||
| 12/4/25 | ![]() Focus on China | ESMO prostate cancer highlights | Another of our special Themed Podcasts focussed on prostate cancer in China, supported by our Gold Partner, Bayer. We are joined as ever by our China Editor, Dr Yao Zhu (Fudan University Shanghai Cancer Centre), and also special guest Dr Yige Bao (SCU Xiamen Hospital). Not only do we learn about pandas in West China, but also some great highlights from the recent ESMO Annual Meeting in Berlin! Hosted as ever by Dr Renu Eapen and Prof Declan Murphy Even better on our YouTube channel | 40m 08s | ||||||
| 11/30/25 | ![]() Journal Club #4 | PRECISION and EB-StaR | Episode 4 of our monthly GU Cast Journal Club and today we focus on two important papers in prostate cancer diagnostics and bladder cancer surgery. The PRECISION NEJM paper 2018 is a landmark publication which defined the role of mpMRI in early detection, and changed practice in many countries. The EB-StaR trial should also change practice after its European Urology 2024 publication, but has it??! We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne... | 32m 27s | ||||||
| 11/28/25 | ![]() Let's Visit the ORSI Academy! World class robotic surgery training facility | An exclusive behind-the-scenes look at the world-famous ORSI Academy in Belgium! Declan and Renu travelled to this remarkable facility just outside Ghent in Belgium, jammed full of tens of millions of dollars worth of robotic surgery technology from the world's top providers - Intuitive Surgical, Medtronic, Microport and more. Every day, surgeons from all around the world are getting hands-on experience using the latest robotic surgery technology in an array of training environments. Plus ORS... | 47m 18s | ||||||
| 11/27/25 | ![]() Sexual health following prostate cancer treatment | With Chris Nelson | World-renowned sexual health expert, Dr Chris Nelson, Chief of Psychology at Memorial Sloan-Kettering Cancer Centre, joins us in studio to run through the new Movember-supported "Guidelines for Sexual Health Care for Prostate Cancer Patients". A really helpful overview and structure for anyone working in this field, and for patients and their loved ones. Chris shares his 20-plus years of experience working in this field at one of the world's premier prostate cancer centres. Even better on o... | 32m 54s | ||||||
| 11/15/25 | ![]() Is high-risk BCR really mHSPC?? Live webinar replay | We recently hosted another live webinar for our Gold Partners, Mundipharma, this time asking the question, "Is high-risk BCR actually metastatic prostate cancer??". It's a reasonable question! This podcast was anchored from the GU Cast studio in Melbourne by usual hosts, Renu Eapen and Declan Murphy, joined in person by Andrew Loblaw, radiation oncologist from Toronto, and online by medical oncologist Jeff Goh in Brisbane. Best enjoyed on our YouTube channel if you want to check out the... | 1h 30m 59s | ||||||
| 11/9/25 | ![]() SABR and LuPSMA for mHSPC? Let's talk LUNAR | Dr Amar Kishan (Radiation Oncologist, UCLA, USA), made lots of headlines recently when he presented data from the phase II randomised LUNAR trial of SABR +/- LuPSMA in patients with oligometastatic prostate cancer. So we were very happy when he turned up in Melbourne recently and popped into the GU Cast studio for a chat. We discuss metastasis-directed therapy and bring up our favourite Pokemet analogies, and ask should we not just be offering these patients and ADT/ARPI doublet?! Regu... | 34m 24s | ||||||
| 11/2/25 | ![]() Let's do some UroTraining! WIth Gonzalo Vitagliano & Maxi Ringa | Fun today as we go to the OR to test drive some high-fidelity radical prostatectomy models and chat with the team behind UroTrainer - world leaders in urologic simulation. Urologists Gonzalo Vitagliano and Maxi Ringa join us from Buenos Aries to tell us all about UroTrainer and why they have worked hard to create these beautiful models for trainees to improve their skills in minimally-invasive prostate and kidney surgery. They also tell us about their range of hands-on courses around t... | 24m 58s | ||||||
| 10/30/25 | ![]() In London for #ERUS25 - a festival of robotic surgery! | One of our favourite meetings of the year! The EAU Robotic Urology Section (ERUS) Annual Meeting took place in London recently and was an unashamed exposition of robotic surgery in urology. More than 30 amazing live surgeries, and some fantastic plenary sessions focussing on technical aspects. Multiple different robots, and spectacular telesurgery with surgeons sitting in London, performing robotic surgery up to 8000km away! Join Host Declan Murphy to get a flavour of this year's meeti... | 50m 17s | ||||||
| 10/27/25 | ![]() Journal club #3 | ERSPC and NIAGARA | Episode 3 of our monthly GU Cast Journal Club and today we focus on one classic paper in Urology, and one from recent times - the ERSPC randomised trial of screening in prostate cancer, and the NIAGARA trial evaluating peri-operative immunotherapy in muscle-invasive bladder cancer. We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. Watch out ... | 32m 13s | ||||||
| 10/25/25 | ![]() Augerlicious! The ProsTIC-PCF-GU Cast Global Knowledge Exchange Webinar | Another of our deep-in-the-weeds theranostic webinars in conjunction with our friends at ProsTiC, and the Prostate Cancer Foundation. This one focussed on Terbium-161, a very exciting new option in metastatic prostate cancer. Your hosts are Dr Renu Eapen and Professor Michael Hofman, with Dr Howard Soule and Dr Andrea Miyahira from the Prostate Cancer Foundation. Special guests include Dr James Buteau (Peter Mac, Melbourne, Australia), Dr Alin Chirindel (Universitätsspital Basel), Prof ... | 1h 23m 23s | ||||||
| 10/19/25 | ![]() And in ADDITION....Lu-PSMA improves outcomes in mHSPC | With Scott Tagawa and Michael Hofman | Hot off the press in the Presidential Plenary at #ESMO25, we chat with Dr Scott Tagawa (Weill-Cornell, USA) about the positive data he just presented from the PSMAddition trial. This is an eagerly awaited phase III randmosied trial of patients with mHSPC, to see if the addition of six cycles of Lu-PSMA-617 to a control arm of ADT and an ARPI, could improve rPFS and other endpoints. We are also joined in the studio by Prof Michael Hofman (Peter MacCallum Cancer Centre, AUS), co-PI of the UpFro... | 41m 41s | ||||||
Showing 25 of 230
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
9 placements across 8 markets.
Chart Positions
9 placements across 8 markets.



